Cash flows for Jul 1, 2026 through Sep 30, 2026. Cash basis: Cash and cash equivalents. Beginning cash: Jun 30, 2026. Ending cash: Sep 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Jun 30, 2026
- 24,151,000,000 US dollars. Beginning cash: Cash and cash equivalents
- Operating activities
- negative 3,669,000,000 US dollars. Net cash used.
- Net earnings (loss)
- negative 65,000,000 US dollars
- Depreciation and amortization
- 299,000,000 US dollars
- Stock compensation expense
- 52,000,000 US dollars
- Impairment
- 0 US dollars
- Deferred income taxes
- 69,000,000 US dollars
- (Gain) loss on divestitures, net
- 15,000,000 US dollars
- Premium and trade receivables
- negative 2,256,000,000 US dollars
- Other assets
- 891,000,000 US dollars
- Medical claims liabilities
- 1,292,000,000 US dollars
- Unearned revenue
- negative 26,000,000 US dollars
- Accounts payable and accrued expenses
- negative 3,071,000,000 US dollars
- Other long-term liabilities
- negative 999,000,000 US dollars
- Other operating activities, net
- 131,000,000 US dollars
- (Gain) loss on debt extinguishment
- negative 1,000,000 US dollars
- Investing activities
- 916,000,000 US dollars. Net cash provided.
- Capital expenditures
- negative 194,000,000 US dollars
- Purchases of investments
- negative 1,183,000,000 US dollars
- Sales and maturities of investments
- 2,290,000,000 US dollars
- Divestiture proceeds, net of divested cash
- 3,000,000 US dollars
- Financing activities
- negative 584,000,000 US dollars. Net cash used.
- Proceeds from long-term debt
- 0 US dollars
- Payments and repurchases of long-term debt
- negative 568,000,000 US dollars
- Common stock repurchases
- negative 24,000,000 US dollars
- Proceeds from common stock issuances
- 8,000,000 US dollars
- Other financing activities, net
- 0 US dollars
- Purchase of noncontrolling interest
- 0 US dollars
- Operating adjustment reconciliation
- 6,418,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 592,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 2,293,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 0 US dollars
- Difference in the filed cash totals (calculated)
- negative 114,000,000 US dollars. Out of cash; drawn as the small gray flow above ending cash.
- Ending cash on Sep 30, 2026
- 20,700,000,000 US dollars. Ending cash: Cash and cash equivalents
- Cash sources and uses
- 25,067,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 3,451,000,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- Operating cash flow
- negative 3,669,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 194,000,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- negative 3,863,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.